The companies entered into non-prosecution agreements to resolve allegations that they violated the US Federal Food, Drug, and Cosmetic Act by failing to prevent merchants from selling and importing illegal drugs, chemicals and pill presses into the US through Alibaba's e-commerce platforms
FILE PHOTO: The US Justice Department said Alibaba and its US-based
payment processor, AUS Merchant Services, agreed to accept responsibility for the acts of their officers and employees and enhance their compliance programmes
| Photo Credit:
Chinese technology and
e-commerce giant Alibaba and its US-based payment
Alibaba to pay $600 million to resolve US drug sales probe
Alibaba and its US payment processor will pay 600 million dollars to settle a DOJ probe into illegal drug sales
Alibaba to pay $600M to resolve US drug sales probe
Alibaba, AUS Merchant Services to pay $600 million to resolve alleged illegal pharmaceuticals sales, DOJ says
Alibaba agrees to pay $600M to settle federal probe into drug sales
Alibaba to pay US$600 million to settle US probe into illegal product sales
Alibaba to pay US $600m to settle allegations it allowed illegal drug and equipment sales
Alibaba to pay US $600M to settle allegations it allowed illegal sales
Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
Correction to Alibaba, U.S. Payment Processor in DOJ Settlement Article
WASHINGTON, July 1 : Chinese technology and e-commerce giant Alibaba and its U.S.-based payment processor have agreed to pay…
Alibaba admitted its platform failed to prevent 80,000 illegal pharmaceutical purchases worth over 200 million dollars between…
Alibaba will pay $600 million to settle a DOJ investigation into illegal pharmaceutical sales on Alibaba.com and AliExpress.com…
WASHINGTON, July 1 : The U.S. Justice Department said on Wednesday that Alibaba and AUS Merchant Services have agreed to pay $600…
Alibaba and its US payment processor will pay $600 million to settle a federal investigation into illegal drug sales facilitated…
Amount resolves dispute with US government over allegations firm sold and imported illegal pharmaceuticals and controlled…
